लोड हो रहा है...
Rebound of medication abortion in Texas following updated mifepristone label
BACKGROUND: In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label. METHODS: Using data collected directly from Texas abortion facilities, we evaluated changes in the provision and use of medi...
में बचाया:
| में प्रकाशित: | Contraception |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6852656/ https://ncbi.nlm.nih.gov/pubmed/30684470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2019.01.001 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|